Study your flashcards anywhere!

Download the official Cram app for free >

  • Shuffle
    Toggle On
    Toggle Off
  • Alphabetize
    Toggle On
    Toggle Off
  • Front First
    Toggle On
    Toggle Off
  • Both Sides
    Toggle On
    Toggle Off
  • Read
    Toggle On
    Toggle Off
Reading...
Front

How to study your flashcards.

Right/Left arrow keys: Navigate between flashcards.right arrow keyleft arrow key

Up/Down arrow keys: Flip the card between the front and back.down keyup key

H key: Show hint (3rd side).h key

A key: Read text to speech.a key

image

Play button

image

Play button

image

Progress

1/40

Click to flip

40 Cards in this Set

  • Front
  • Back
  • 3rd side (hint)
ANY CHEMICAL SUBSTANCE THAT HAS AN EFFECT ON LIVING TISSUE BUT IS NOT USED AS A FOOD
DRUG
ZERO TOLERANCE
RELIEVES SYMPTOMS OF DISEASE
THERAPEUTIC
PREVENT OR DECREASE SEVERITY OF DIESEASE
PROPHYLACTIC
A TOOL TO PREVENT STDS
THE SCIENCE OF DOSAGES
POSOLOGY
THE BRANCH OF PHARMACOLOGY THAT DEALS WITH THE SCIENTIFIC STUDY OF ABSORPTION, DISTRIBUTION AND EXCRETION (ADME)
PHARMACOKINETICS
THE PROCESS BY WHICH A SUBSTANCE IS TAKEN UP FROM THE SITE OF ADMINISTRATION THE SYSTEM
ABSORPTION
A=A
ADMINSTRATION=
THE PROCESS OF MOVEMENT OF THE DRUG THROUGH THE BLOOD AND TRANSFER FROM THE BLOOD TO OTHER BODILY FLUIDS AND TISSUES
DISTRUBUTION
NOT A STREET PHARMACISIT, BUT A DRUG ....
THE TRANSFORMATION OF THE DRUG BY PHYSIOLOGICAL PROCESSES OF THE BODY INTO OTHER FORMS, USUALLY LESS POTENT OR TOXIC THAN THE ORIGINAL FORM THAT CAN BE ELIMINATED
METABOLISM
YOU WANT TO TRANSFORM YOUR BODY, YOU WANT TO RAISE YOUR...
THE STUDY OF DRUG ACTION ON LIVING ORGANISMS
PHARMACODYNAMICS
ACTION
THE STUDY OF OF THE ECONOMIC ASPECTS OF DRUGS
PHARMACOECONOMICS
ECONOMY
ANY CONDITION ACCOMPANYING OR RESULTING FROM A DISEASE, DISORDER OR OTHERABNORMALITY THAT PROVIDES EVIDENCE FOR ITS EXISTENCE
SYMPTOMS
GENERALLY REFERRED TO AS THE PATIENT'S DESCRIPTION OF THE PHYSICAL SENSATION EXPERIENCED
A SET OF S/SX THAT OCCUR TOGETHER AND CHARACTERIZE A PARTICULAR DISEASE OR DISORDER
SYNDROME
DISEASE=DISORDER=DOWNS
LOCATION IN THE BODY WHERE THE DRUG EXERTS ITS EFFECT. INCLUDES LOCAL USE OR SYSTEMIC USE
SITE OF ACTION
REFERS TO THE SITE SPECIFIC APPLICATION OF DRUGS, SUCH AS AN ANALGESIC OINTMENT APPLIED TO A BURN
LOCAL
YOU APPLY AN OINTMENT, IT NUMBS CREATING A ... ANALGESIC
REFERS TO APPLICATION OF A DRUGBY MEANS OF ABSORPTION INTO THE BLOOD AND SUBSEQUENT TRANSPORTATION THROUGHOUT THE BODY
SYSTEMIC
ABSORBS INTO BLOOD
HOW THE DRUG PRODUCES ITS EFFECTS IN THE BODY. INCLUDES AGONIST/ANTAGONIST EFFECT/NONSPECIFIC MEMBRANE LIPID INTERACTION/PROTEIN BINDING/OSMOTIC EFFECT
MECHANISM OF ACTION
LOCATION ON THE SURFACE OR WITHIN THE CELL THAT CONTAIN SPECIFIC PROTEIN MOLECULES THAT BIND TO OTHER SPECIFIC MOLECULES, PRODUCING SOME EFFECT IN THE CELL.
RECEPTOR SITE
LOCATION
A DRUG THAT BINDS TO PARTICULAR RECEPTOR SITE AND TRIGGERS THE CELLS RESPONSE IN A SIMILAR WAY TO THE BODY'S OWN CHEMICAL MESSENGER
AGONIST
RESPONSE IN A SIMILAR WAY
A DRUG THAT BINDS TO A PARTICULAR RECEPTOR SITE AND BLOCKS THE ACTION OF THE ENDOGENOUS CHEMICAL MESSENGER WITHOUT TRIGGERING THE CELL'S RESPONSE.
ANTAGONIST
BLOCKS THE ACTION
THE MAXIMUM THERAPEUTIC DOSE, ABOVE WHICH NO IMPROVED CLINICAL RESPONSE WILL OCCUR
CEILING EFFECT
THE LENGTH OF TIME A DRUG IS AT THERAPEUTIC CONCENTRATION LEVEL
DURATION OF ACTION (DOA)
THE TIME PERIOD REQUIRED AFTER ADMINISTRATION OF A DRUG TO ACHIEVE THE DESIRED RESPONSE, OR THERAPEUTIC CONCENTRATION LEVEL.
ONSET OF ACTION
TIME PERIOD
THE DRUG DOSE THAT WILL PRODUCE A THERAPEUTIC RESPONSE IN 50 PERCENT OF THE POPULATION WHO RECEIVED THE DRUG
EFFECTIVE DOSE 50
THE DOSAGE THAT WILL KILL 50% OF THE POPULATION
LETHAL DOSE 50
UNUSUAL OR UNEXPECTED RESPONSE TO A DRUG. PECULIAR TO THE INDIVIDUAL AND SOMETIMES HAVE GENETIC CAUSES
IDIOSYNCRASY
A LOCAL OR GENERAL IMMUNE RESPONSE IN WHICH THE IMMUNE SYSTEM OVERREACTS TO AN OTHERWISE HARMLESS SUBSTANCE
ALLERGY
RESULTING IN IMMEDIATE LIFE THREATENING RESP DISTRESS, USUALLY FOLLOWED BY VASCULAR COLLAPSE AND SHOCK AND ACCOMPANIED BY HIVES
SEVERE ALLERGIC REACTION
LONGEST DIFFICULT NAME OF THE CHEMICAL MAKE UP THE DRUG AND RELATES TO THE CHEMICAL AND MOLECULAR STRUCTURE
CHEMICAL NAME
A SHORTENED VERSION OF THE CHEMICAL NAME THAT THE MANUFACTURER GIVES THE DRUG
GENERIC NAME
BEGINS WITH LOWERCASE LETTER AND CAN BE USED BY OTHER MANUFACTURERS
THE NAME UNDER WHICH THE MANUFACTURER HAS PATENTED THE DRUG
TRADE/BRAND NAME
THE BRANCH OF PHARMACOLOGY THAT DEALS WITH BIOLOGICAL, BIOCHEMICAL, AND ECONOMIC FEATURES OF NATURAL DRUGS AND THEIR CONSTITUENTS
PHARMACOGNOSY
PROVIDES STANDARDS FOR DRUGS OF THERAPEUTIC USEFULNESS AND PHARMACEUTICAL NECESSITY.
US PHARMACOPEIA AND NATIONAL FORMULARY
THE MOST WIDELY USED TEXT/REFERENCE IN AMERICAN PHARMACIES
REMINGTON: THE SCIENCE AND PRACTICE OF PHARMACY
THE THERAPEUTIC DOES IS CALCULATED ON AN AVERAGE ADULT
24 YEARS WHO WEIGHS 150 POUNDS
DRUGS GROUPED ACCORDING TO THEIR SOURCE, WHETHER ANIMAL, VEGETABLE, OR MINERAL IN ORIGIN
GENERAL
DRUGS GROUPED BY THEIR CHEMICAL CHARACTERISTICS
CHEMICAL
DRUGS ARE GROUPED ACCORDING TO THEIR ACTION ON THE BODY
THERAPEUTIC
HISTAMINE H2 RECEPTOR ANTAGONISTS
BLOCKS HISTAMINES THAT CAUSE AN INCREASE OF OF GASTRIC ACID SECRETION IN THE STOMACH. RELIEVES SYMPTOMS OF PEPTIC ULCERS
EFFECTIVE AGAINST BOTH GRAM-POSITIVE AND GRAM-NEGATIVE ORGANISMS. WERE THE FIRST EFFECTIVE CHEMOTHERAPEUTIC AGENTS AVAILABLE
SULFONAMIDES
MOST EFFECTIVE AND LEAST TOXIC OF THE ANTIMICROBIAL AGENTS
PCN